A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] |
O'Reilly, Richard, MD |
A Phase I/II Study of AT7519M with and without Bortezomib in Patients with Previously Treated Multiple Myeloma
[Protocol 10-151] |
Landau, Heather, MD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes
[Protocol 06-054] |
Klimek, Virginia, MD |
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125] |
Boulad, Farid, MD |
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174] |
Gerecitano, John, MD, PhD |
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor
[Protocol 01-062] |
Boulad, Farid, MD |
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] |
Hassoun, Hani, MD |
A Phase II Study of Maitake Mushroom Extract in Patients with Low-Risk, Untreated Myelodysplastic Syndrome
[Protocol 09-094] |
Wesa, Kathleen, MD |
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis
[Protocol 07-006] |
Landau, Heather, MD |
A Phase II Study of Midostaurin in Patients with Aggressive Systemic Mastocytosis or Mast Cell Leukemia
[Protocol 10-006] |
Heaney, Mark, MD, PhD |
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
[Protocol 08-008] |
Castro-Malaspina, Hugo, MD |
A Phase II Study of TKI258 in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 10-221] |
Hassoun, Hani, MD |
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia
[Protocol 08-031] |
Boulad, Farid, MD |
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
[Protocol 07-035] |
Hsu, Katharine, MD, PhD |
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050] |
O'Reilly, Richard, MD |
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] |
Klimek, Virginia, MD |
A Phase III Study of Pomalidomide versus Placebo in Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis Who Are Dependent on Red Blood Cell Transfusions
[Protocol 11-025] |
Heaney, Mark, MD, PhD |
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders
[Protocol 10-150] |
O'Reilly, Richard, MD |
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
[Protocol 08-087] |
Barker, Juliet, MBBS |
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051] |
Koehne, Guenther, MD, PhD |
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038] |
Papanicolaou, Genovefa, MD |
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] |
Landau, Heather, MD |
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy
[Protocol 06-014] |
Barker, Juliet, MBBS |
Expanded Access Study to Evaluate Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 11-158] |
Lendvai, Nikoletta, MD |
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia
[Protocol 06-056] |
Castro-Malaspina, Hugo, MD |
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123] |
Meyers, Paul, MD |
Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017] |
Jurcic, Joseph, MD |
Phase II Study of Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 10-228] |
Lendvai, Nikoletta, MD |
Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
[Protocol 11-061] |
Hassoun, Hani, MD |
Pilot Study of MAGE-A3 Vaccination as Consolidation Therapy for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
[Protocol 10-216] |
Lendvai, Nikoletta, MD |
Pilot Trial of Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant
[Protocol 11-105] |
Landau, Heather, MD |
